Cytomegalovirus (CMV) resistance in CD34(+) selected hematopoietic cell transplant (HCT) recipients

BACKGROUND: Cytomegalovirus (CMV) viremia after CD34(+) selected hematopoietic stem cell transplant (HCT) often requires prolonged antiviral therapy. We report rates and outcomes of resistant CMV in a contemporary cohort of CD34(+) selected HCT recipients managed preemptively. METHODS: We retrospect...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Transpl Infect Dis
Prif Awduron: Kim, Seong Jin, Huang, Yao-Ting, Foldi, Julia, Lee, Yeon Joo, Maloy, Molly, Giralt, Sergio A., Jakubowski, Ann A., Papanicolaou, Genovefa A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2018
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5988949/
https://ncbi.nlm.nih.gov/pubmed/29570237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.12881
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg